e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Novel biomarkers and old parameters in approaching pulmonary diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical decision making in alpha
1
antitrypsin deficiency emphysema – Methodologies to determine individual rates of FEV
1
decline
A. I. Shamji, A. C. Bradi, K. R. Chapman (Toronto, Canada)
Source:
Annual Congress 2010 - Novel biomarkers and old parameters in approaching pulmonary diseases
Session:
Novel biomarkers and old parameters in approaching pulmonary diseases
Session type:
Oral Presentation
Number:
2107
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. I. Shamji, A. C. Bradi, K. R. Chapman (Toronto, Canada). Clinical decision making in alpha
1
antitrypsin deficiency emphysema – Methodologies to determine individual rates of FEV
1
decline. Eur Respir J 2010; 36: Suppl. 54, 2107
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Evaluation of difficult asthma – a single centre experience
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009
Clinical evaluation in 14 cases of diffuse alveolar hemorrhage – Relationship between initial findings and prognosis –
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010
Patient assessments of ease of use of Genuair® versus Aerolizer® and HandiHaler®
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011
Documentation & accuracy of smoking status – An educational need?
Source: Annual Congress 2011 - Smoking cessation science and smoking-related disorders
Year: 2011
Smoking assessment & treatment in hospital: Are we providing ‘right care‘ and/or missing cannabis-smoking?
Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment
Year: 2011
Study of the use of Chartis® pulmonary assessment system to optimize subject selection for endobronchial lung volume reduction (ELVR) – Results and subgroup analysis
Source: Annual Congress 2011 - Endoscopic lung volume reduction: hype or hope?
Year: 2011
How should we investigate the child with difficult asthma – Is there any evidence?
Source: Annual Congress 2010 - Quality of life, asthma control and monitoring childhood asthma
Year: 2010
Scoring systems for estimation of severity community acquired pneumonia – our impressions
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009
Tackling tuberculosis among hard to reach groups in London – The Find&Treat experience
Source: Annual Congress 2010 - Tuberculosis control
Year: 2010
Why are we so poor at following guidelines? – A detailed analysis of a bronchiolitis pathway and its implementation
Source: Annual Congress 2010 - Paediatric epidemiology: infection, prematurity and congenital abnormalities
Year: 2010
Transcutaneous measurement of pCO
2
(p
tc
CO
2
): Time delay from change in alveolar pCO
2
to first response in p
tc
CO
2
Source: Annual Congress 2011 - Sleep and weight: heavy under pressure
Year: 2011
Stability of severe asthma phenotype – 1 year follow up BIOAIR study
Source: Annual Congress 2010 - Asthma and COPD: understanding through monitoring
Year: 2010
Airway resistances: R
aw
, sR
aw
, sR
eff
– Which is the best determinant of airway function?
Source: Annual Congress 2010 - Lung function from infancy to adulthood
Year: 2010
The results of drug resistance survey of MDR-strains on second line drugs obtains in national reference laboratory – " M.Nasta " Institute – Bucharest
Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2011
Over-reading spirometry – Man or machine?
Source: Annual Congress 2011 - Quality control in lung function and exercise-related issues
Year: 2011
Ways to shorten the lung clearance index measurement I – Are three measurements needed?
Source: Annual Congress 2012 - New understanding of childhood lung disease through physiological measurement
Year: 2012
Clinical correlation & evaluation of spirometry in children with asthma
Source: Annual Congress 2011 - Biological correlates and comorbidities of childhood asthma/allergy
Year: 2011
Usability evaluation of NEXThaler® versus Diskus® and Turbuhaler®
Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma
Year: 2012
Ways to shorten the lung clearance index measurement ΙΙ – How long to wash?
Source: Annual Congress 2012 - New developments in paediatric respiratory physiology
Year: 2012
Late Breaking Abstract: Inhalation technique errors and education effects in the group of patients using Aerolizer® – The real life study
Source: Annual Congress 2010 - Medical education: methodology
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept